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Abstract
Purpose It is well known that a significant proportion of
heart failure patients (10–44 %) do not show improvement
in symptoms or functioning from cardiac resynchronization
therapy (CRT), yet no study has examined patient-reported
health status trajectories after implantation.
Methods A cohort of 139 patients with a CRT-defibril-
lator (70 % men; age 65.7 ± 10.1 years) completed the
Kansas City Cardiomyopathy Questionnaire (KCCQ) prior
to implantation (baseline) and at 2, 6, and 12–14 months
post-implantation. Latent class analyses were used to
identify trajectories and associates of disease-specific
health status over time.
Results All health status trajectories showed an initial
small to large improvement from baseline to 2-month fol-
low-up, whereafter most trajectories displayed a
stable pattern between short- and long-term follow-up.
Low educational level, NYHA class III/IV, smoking, no
use of beta-blockers, use of psychotropic medication,
anxiety, depression, and type D personality were found to
be associated with poorer health status in unadjusted
analyses. Interestingly, subgroups of patients (12–20 %)
who experienced poor health status at baseline improved to
stable good health status levels after implantation.
Conclusions Levels of disease-specific health status vary
considerably across subgroups of CRT-D patients. Classi-
fication into poorer disease-specific health status trajecto-
ries was particularly associated with patients’
psychological profile and NYHA classification. The timely
identification of CRT-D patients who present with poor
disease-specific health status (i.e., KCCQ score\ 50) and a
distressed psychological profile (i.e., anxiety, depression,
and/or type D personality) is paramount, as they may
benefit from cardiac rehabilitation in combination with
psychological intervention.
Keywords Heart failure  Cardiac resynchronization
therapy  Health status  KCCQ  Trajectories
Introduction
Heart failure (HF) is a complex and debilitating clinical
syndrome, characterized by symptoms of fatigue, dyspnea,
diminished exercise capacity, fluid retention, reduced
quality of life, and reduced survival [1]. Cardiac resyn-
chronization therapy (CRT), with or without an
implantable cardioverter-defibrillator, is a well-established
treatment in selected patients with drug-refractory HF and
an electrical conduction delay [2]. Several large-scale
randomized controlled trials have demonstrated that CRT
improves not only prognosis, but also patient-reported
health status [3, 4].
Patient-reported health status, including symptoms,
functioning, and health-related quality of life, has become
an increasingly important outcome measure in cardiac
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patients [5]. Thus far, the majority of studies on health
status in CRT and HF patients reported on prevalence rates
or change in mean scores over time [3]. However, change
in health status of the total sample is fairly meaningless if
there are in fact multiple subgroups that have different
means and different patterns of change over time (i.e.,
trajectories) [6]. Although it is well known that a signifi-
cant proportion of patients (10–44 %) do not show
improvement in symptoms or functioning from CRT [7],
no study to date has examined patient-reported health sta-
tus trajectories after implantation.
Latent class analysis would permit the identification of
patients reporting persistently low health status, who need
additional care above and beyond standard HF manage-
ment. This is of utmost importance, since poor patient-
reported health status has been shown to predict mortality
and rehospitalization in HF patients independent of tradi-
tional risk factors [8]. Additionally, CRT studies have
shown that the majority of established outcome measures,
including New York Heart Association (NYHA) functional
class and echocardiographic and hemodynamic parameters,
are only marginally associated with patient-reported out-
comes [9]. By contrast, the role of psychological factors
has largely been neglected in this context, although such
factors may contribute more to differences in patient-re-
ported outcomes [9]. Knowing which factors are charac-
teristics of patients with (persistently) reduced patient-
reported health status after implantation may provide tar-
gets for intervention, thereby improving the clinical
response to CRT.
Hence, the goal of the current study was to identify the
trajectories and demographic, clinical, and psychological
associates of disease-specific health status in the first 14
months after CRT-defibrillator (CRT-D) implantation.
Methods
Study design and participants
The sample comprised HF patients receiving a first-time
CRT-D between January 2009 and August 2011 at the
University Medical Center Utrecht (UMCU), the Nether-
lands. All patients participated in the ‘The influence of
PSYchological factors on health outcomes in HEART
failure patients treated with Cardiac Resynchronization
Therapy (PSYHEART-CRT): A prospective, single-center,
observational study’. Patients were not eligible for partic-
ipation: when aged\18 or[85 years; if they had insuffi-
cient knowledge of the Dutch language; a history of
psychiatric illness other than affective/anxiety disorders;
cognitive impairments; or if they were on the waiting list
for heart transplantation. Patients were asked to complete a
set of standardized and validated questionnaires 1 day prior
to implantation (baseline) and 2, 6, and 12–14 months after
implantation. The study protocol was approved by the
Medical Ethics Committee of the UMCU. The study was
conducted in accordance with the Helsinki Declaration.
Measures
Demographic and clinical variables
Information on demographic and clinical characteristics
was captured via purpose-designed questions in the base-
line questionnaire and/or via patients’ medical records.
Patient-reported health status
The Kansas City Cardiomyopathy Questionnaire (KCCQ)
was used to assess HF-specific health status [10]. The
KCCQ is a 23-item self-report questionnaire that taps into
the following dimensions: physical limitation, symptoms,
social function, and quality of life. In the current study, the
following summary scores within the KCCQ were calcu-
lated: clinical summary score (KCCQ-CS), quality of life
(KCCQ-QoL), and social limitation (KCCQ-SL). The
KCCQ-CS is the mean of the physical limitation and
symptoms score, thus representing physical health status.
Scores are transformed into a score from 0 to 100, with
higher scores representing less physical or social limitation,
less symptoms, or better quality of life. Poor health status is
defined as a KCCQ (sub)scale score of\50 points. The
minimal clinically meaningful difference in KCCQ scores
is 5 points [11]. The validity and reliability of the KCCQ
have previously been established and the measure was
shown to be highly sensitive to clinical change in HF
patients [10, 11].
Psychological variables and personality
The Patient Health Questionnaire (PHQ-9) was used to
measure depressive symptoms at baseline. This is a nine-
item questionnaire with the items mirroring the diagnostic
criteria for major depressive disorder. Patients are asked to
rate how often each symptom has bothered them during the
past 2 weeks on a scale from 0 (‘not at all’) to 3 (‘nearly
every day’) (score range 0–27). Patients who score C10
points are considered to have moderate or severe depres-
sive symptoms [12]. The PHQ-9 is brief, responsive to
change over time, and has good reliability and validity in
medical outpatients and patients with HF.
The state anxiety subscale of the State-Trait Anxiety
Inventory (STAI-S) was used to measure baseline symp-
toms of anxiety [13]. All items are rated on a four-point
Likert scale ranging from 1 (‘not at all’) to 4 (‘very much
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so’) (score range 20–80). Higher scores indicate higher
levels of anxiety. A cutoff score C 40 indicates probable
clinical levels of anxiety. The STAI-S has shown to be a
valid and reliable measure [13].
The 14-item type D scale (DS14) was administered at
baseline to assess Type D personality, which is defined as
the tendency to experience negative emotions across time
and situations paired with the tendency to inhibit these
emotions [14]. The DS14 comprises two subscales, ‘neg-
ative affectivity’ (e.g., ‘I often feel unhappy’) and ‘social
inhibition’ (e.g., ‘I am a closed kind of person’), each
consisting of seven items. Items are answered on a five-
point Likert scale ranging from 0 (‘false’) to 4 (‘true’),
with total scores ranging from 0 to 28 for both subscales. A
standardized cutoff score of C 10 on both subscales was
used to identify patients with a Type D personality [15].
The DS14 is a valid and reliable scale [14].
Statistical analyses
All patients (n = 139) had at least 1 measurement of health
status and were included in the analyses. With respect to
physical health status, 112 (81 %), 13 (9 %), 12 (9 %), and
2 (1 %) patients had 4, 3, 2, and 1 measurement(s),
respectively. With respect to quality of life, 111 (80 %), 13
(9 %), 13 (9 %), and 2 (1 %) had 4, 3, 2, and 1 measure-
ment(s), respectively. With respect to social limitation, 96
(69 %). 25 (18 %), 15 (11 %), and 3 (2 %) had 4, 3, 2, and
1 measurement(s), respectively. All available data were
used in the analyses.
Latent GOLD 5.0 [16] was used to fit a number of latent
class regression models in order to determine how many
latent classes (i.e., health status trajectories) could be
identified. Time was entered as a nominal predictor,
whereas health status (KCCQ-CS, KCCQ-QoL, or KCCQ-
SL) was treated as continuous outcome. For each depen-
dent variable (i.e., KCCQ-CS, KCCQ-QoL, and KCCQ-
SL), eight models were compared with an increasing
number of trajectories (1–8 trajectories). To determine the
optimal number of trajectories, the Bayesian information
criterion (BIC) was used. The BIC is a criterion for model
selection among a finite set of models, with a lower BIC
indicating a better fit. In case of a difference in BIC of\3
between two consecutive models, the least complex model
was preferred (i.e., with the lowest number of trajectories).
Subsequently, SPSS 20.0 for Windows (SPSS Inc., Chi-
cago, IL, USA) was used to determine which variables
were univariately associated with health status class
membership, while the corresponding p values were
obtained using the Step-3-Dependent analysis procedure in
Latent GOLD which corrects for classification error to
prevent bias [16]. This correction is performed by obtain-
ing estimates of the number of classification errors when
assigning individuals to latent classes, which enables for
proportional assignment in which individuals are treated as
belonging to each of the classes with weights equal to the
posterior membership probabilities. Step-3-Dependent
analysis yields a separate bivariate analysis for each
dependent variable (i.e., demographic, clinical, or psy-
chological variable), which is similar to cross-tabulations
(for categorical variables) and ANOVAs (for continuous
variables). The Wald (=) statistic, which tests the equality
of each set of regression effects across classes, was used to
evaluate statistical significance. In order to correct for
multiple comparisons, the Bonferroni correction was
applied.
Results
Patient characteristics
The sample comprised 139 CRT-D patients with a mean
age of 65.7 ± 10.1 years, and 97 (70 %) patients were
male. The underlying HF etiology was ischemic in 49 % of
the patients, and 21, 77, and 2 % of patients were classified
as having NYHA functional class II, III, and IV, respec-
tively. Forty-three percent of patients reported clinically
relevant levels of anxiety, 23 % of patients experienced
moderate to severe symptoms of depression, and 23 % of
patients were classified as having a Type D personality.
Complete information on the demographic and clinical
characteristics of the patient sample is given in Table 1.
Trajectories of physical health status (KCCQ-CS)
Based on the BIC, a five-class model was found to be the
best fitting model for physical health status (Table 1). The
class sizes of the physical health status trajectories varied
between 14 (10 %) and 41 (29 %) patients, and the tra-
jectories explained 71 % of the total variance in KCCQ-CS
scores. Trajectories differed from each other with respect to
intercept (Wald (=) 355.47, p\ .001) and time slope
(Wald (=) 200.69, p\ .001).
All five KCCQ-CS trajectories showed an initial
improvement from baseline to 2-month follow-up (Fig. 1a).
Three of them showed a small increase, whereas two tra-
jectories showed a large increase (37.3 and 27.1 points on the
KCCQ-CS for the ‘Poor-Good’ and ‘Fairly good-Excellent’
trajectory, respectively). After this initial improvement in
physical health status, patients in all but one trajectory
showed subsequent stability between short- and long-term
follow-up. Four trajectories showed stable good to excellent
physical health status, whereas patients in the ‘Poor’ tra-
jectory (comprising the largest group of patients (29 %))
reported poor physical health status that deteriorated even
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more during long-term follow-up, with a mean KCCQ-CS
score between 50.9 and 40.9 over time.
Demographic, clinical, and psychological characteristics
at baseline stratified by KCCQ-CS status class are given in
Table 2. Low educational level, NYHA class III/IV, and
depression were associated with poorer physical health
status. The relationship between ICD shock and physical
health status was less clear. The highest percentages of ICD
shock were found in patients in the ‘Poor’ (13 %) and
‘Good’ trajectories (17 %).
As shown in Fig. 1a, two classes of patients had a mean
KCCQ-CS score \50 prior to implantation, which is
defined as poor physical health status. At follow-up,
patients in the ‘Poor-Good’ trajectory reported a strong
improvement in physical health status in the first 2 months,
whereas patients in the ‘Poor’ trajectory reported further
deterioration. Post hoc analyses revealed a trend for gen-
der, with proportionally more men in the poor physical
health status trajectory as in the improving physical health
status trajectory (68 vs. 46 %, p = .069). Furthermore, a
trend was found for depression, with patients in the poor
physical health status trajectory having a higher prevalence
of depression prior to implantation as compared with
patients in the improving physical health status trajectory
(51 vs. 29 %, p = .061).
Trajectories of quality of life (KCCQ-QoL)
With reference to quality of life, also a five-class model
was preferred (Table 1). The class sizes of the quality of
life trajectories varied between 9 (6 %) and 50 (36 %), and
the trajectories explained 74 % of the total variance in
KCCQ-QoL scores. Trajectories differed from each other
with respect to intercept (Wald (=) 416.06, p\ .001) and
time slope (Wald (=) 218.26, p\ .001).
All KCCQ-QoL trajectories showed an initial improve-
ment from baseline to 2-month follow-up (Fig. 1b). Three
of them showed a moderate increase (between 5.7 and 8.8
points on the KCCQ-QoL), whereas two trajectories
showed a large increase (66.7 and 24.4 points on the
KCCQ-QoL for the ‘Very poor-Good’ and ‘Fairly good-
Table 1 Identification of the
number of latent classes for
health status after CRT-D
implantation
Solution Physical health status Quality of life Social limitation
LL Npar BIC LL Npar BIC LL Npar BIC
1 Class -2334.13 5 4692.93 -2367.98 5 4760.63 -2359.51 5 4743.70
2 Classes -2212.71 11 4479.69 -2286.94 11 4628.16 -2255.51 11 4565.29
3 Classes -2176.28 17 4436.44 -2259.92 17 4603.73 -2217.67 17 4519.24
4 Classes -2152.69 23 4418.87 -2239.63 23 4592.75 -2191.37 23 4496.22
5 Classes -2135.60 29 4414.30 -2221.30 29 4585.70 -2177.38 29 4497.87
6 Classes -2124.26 35 4421.23 -2210.51 35 4593.72 -2166.43 35 4505.57
7 Classes -2112.40 41 4427.12 -2197.05 41 4596.41 -2153.72 41 4509.76
8 Classes -2103.08 47 4438.08 -2184.38 47 4600.68 -2145.69 47 4523.31
LL log likelihood; Npar number of parameters; BIC Bayesian information criterion
The selected number of classes is marked in bold for each outcome
Fig. 1 a–c Trajectories of physical health status, quality of life, and social limitation after CRT-D implantation
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Very good’ trajectory, respectively). After this initial
improvement in quality of life, all but one trajectory
showed subsequent stability between short- and long-term
follow-up, whereas patients in the ‘Poor’ trajectory repor-
ted poorer quality of life at 14-month follow-up compared
with 6-month follow-up. The ‘Adequate’ trajectory com-
prised the largest group of patients (37 %), with a mean
score between 58.2 and 65.5 over time.
Demographic, clinical, and psychological characteristics
at baseline stratified by KCCQ-QoL status class are given
in Table 3. Low educational level, smoking, no use of beta-
blockers, use of psychotropic medication, anxiety,
depression, and Type D personality were associated with
poorer quality of life. The relationship between use of
amiodarone and quality of life was less clear. The highest
percentages of amiodarone use were found in the ‘Poor’
Table 2 Baseline characteristics stratified by physical health status trajectories after CRT-D implantation*
Baseline variable Missing Total Excellent Fairly good–Excellent Good Poor–Good Poor p value
(n, %) (n = 139) (n = 18) (n = 14) (n = 38) (n = 28) (n = 41)
Demographics
Mean age (SD) 0 (0) 65.7 (10.1) 68.0 (9.9) 63.4 (12.7) 64.8 (11.3) 64.8 (7.9) 66.8 (9.6) .64
Male gender 0 (0) 97 (70) 16 (89) 10 (71) 30 (79) 13 (46) 28 (68) .019
Having a partner 0 (0) 113 (81) 17 (94) 12 (86) 32 (84) 22 (79) 30 (73) .45
Low education 1 (1) 18 (13) 0 (0) 1 (7) 1 (3) 7 (25) 9 (23) <.001
Being employed 1 (1) 30 (22) 5 (28) 4 (29) 11 (29) 2 (7) 8 (20) .51
Clinical variables
Upgrade§ 0 (0) 36 (26) 5 (28) 4 (29) 9 (24) 7 (25) 11 (27) .98
ICD as sec. prevention 0 (0) 26 (19) 7 (39) 2 (15) 5 (13) 6 (21) 6 (15) .34
Ischemic etiology 0 (0) 68 (49) 10 (56) 3 (21) 20 (53) 13 (46) 22 (54) .29
NYHA class III/IV 0 (0) 110 (79) 6 (33) 10 (71) 28 (74) 28 (100) 38 (93) <.001
Mean LVEF (SD) 6 (4) 24.9 (8.6) 27.1 (10.2) 23.2 (7.7) 24.2 (8.7) 26.2 (8.6) 24.4 (8.2) .74
Mean QRS (SD) 11 (8) 162 (25) 163 (24) 166 (22) 162 (28) 165 (26) 160 (24) .92
LBBB 28 (20) 60 (54) 8 (50) 8 (73) 17 (50) 14 (61) 13 (48) .51
ESV responder|| 25 (18) 61 (54) 10 (63) 7 (58) 23 (66) 10 (46) 11 (38) .40
Comorbidity# 6 (4) 79 (59) 8 (47) 4 (31) 24 (63) 17 (63) 26 (68) .55
ICD shock 18 (13) 11 (9) 0 (0) 1 (8) 6 (17) 0 (0) 4 (13) <.001
Smoking 0 (0) 21 (15) 1 (6) 1 (7) 5 (13) 7 (25) 7 (17) .43
Medication use
Amiodarone 0 (0) 17 (12) 4 (22) 2 (14) 3 (8) 1 (4) 7 (17) .38
ACE inhibitors 0 (0) 126 (91) 16 (89) 11 (79) 36 (95) 25 (89) 38 (93) .58
Beta-blockers 0 (0) 108 (78) 15 (83) 10 (71) 31 (82) 23 (82) 29 (71) .60
Statins 0 (0) 84 (60) 14 (78) 3 (21) 20 (53) 19 (68) 28 (68) .018
Psychotropic medication 0 (0) 33 (24) 1 (6) 1 (7) 6 (16) 9 (32) 16 (39) .041
Psychological functioning
Anxiety (STAI-S C 40) 2 (1) 59 (43) 2 (11) 3 (21) 12 (32) 17 (61) 25 (63) .001
Depression (PHQ-9 C 10) 1 (1) 32 (23) 0 (0) 2 (14) 1 (3) 8 (29) 21 (51) <.001
Type D personality 1 (1) 32 (23) 1 (6) 1 (8) 8 (21) 8 (29) 14 (34) .13
ACE angiotensin-converting enzyme; ESV end-systolic volume; ICD implantable cardioverter-defibrillator; LBBB left bundle branch block;
NYHA New York Heart Association; SD standard deviation; sec. secondary
* Results are presented as n (%), unless otherwise indicated. Significant results are printed in bold (Bonferroni’s corrected p value = 0.05/
72 = 6.9e-4)
 p values were obtained using adjusted Step-3-Dependent analysis procedures in Latent GOLD 5.0. All other values were observed values
obtained using SPSS
 Defined as primary education versus secondary education and higher
§ Upgrade from another implantable device, either (biventricular) pacemaker or ICD without cardiac resynchronization therapy
|| Echocardiographic response was defined as a decrease in left ventricular end-systolic volume of C15 % measured at 6-month follow-up
# Comorbidity = atrial fibrillation, chronic obstructive pulmonary disease, diabetes, or renal failure
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(30 %) and ‘Excellent’ trajectories (22 %), whereas no
patients in the ‘Very poor-Good’ trajectory used
amiodarone.
As shown in Fig. 1b, two classes of patients had a mean
KCCQ-QoL score around 20 points prior to implantation,
which represents very poor quality of life. At follow-up,
patients in the ‘Very poor-Good’ trajectory reported an
enormous improvement in quality of life over time,
whereas patients in the ‘Poor’ trajectory reported initial
improvement, but lost their gain in quality of life between
6- and 14-month follow-up. Post hoc analyses showed that
patients in the ’Poor’ trajectory more often used amio-
darone prior to implantation than patients in the ’Very
poor-Good’ trajectory (30 vs. 0 %, p = .021).
Table 3 Baseline characteristics stratified by quality of life trajectories after CRT-D implantation*
Baseline variable Missing Total Excellent Fairly good–Very
good
Adequate Very poor–
Good
Poor p value
(n, %) (n = 139) (n = 9) (n = 42) (n = 50) (n = 18) (n = 20)
Demographics
Mean age (SD) 0 (0) 65.7 (10.1) 68.1 (9.9) 67.1 (10.0) 63.8 (10.8) 64.7 (8.8) 67.1 (9.9) .79
Male gender 0 (0) 97 (70) 7 (78) 31 (74) 36 (72) 10 (56) 13 (65) .50
Having a partner 0 (0) 113 (81) 8 (89) 36 (86) 39 (78) 16 (89) 14 (70) .57
Low education 1 (1) 18 (13) 0 (0) 2 (5) 5 (10) 6 (33) 5 (26) <.001
Being employed 1 (1) 30 (22) 2 (22) 7 (17) 16 (33) 3 (17) 2 (10) .24
Clinical variables
Upgrade§ 0 (0) 36 (26) 2 (22) 11 (26) 15 (30) 1 (6) 7 (35) .13
ICD as sec. prevention 0 (0) 26 (19) 3 (33) 8 (19) 8 (16) 2 (11) 5 (25) .44
Ischemic etiology 0 (0) 68 (49) 6 (67) 18 (43) 26 (52) 9 (50) 9 (45) .76
NYHA class III/IV 0 (0) 110 (79) 2 (22) 28 (67) 45 (90) 17 (94) 18 (90) .001
Mean LVEF (SD) 6 (4) 24.9 (8.6) 28.2 (11.3) 24.7 (8.5) 24.4 (9.0) 25.1 (7.9) 25.2 (7.5) .98
Mean QRS (SD) 11 (8) 162 (25) 156 (20) 168 (26) 160 (26) 161 (22) 162 (26) .39
LBBB 28 (20) 60 (54) 5 (56) 21 (58) 18 (45) 10 (71) 6 (50) .53
ESV responder|| 25 (18) 61 (54) 6 (67) 20 (54) 21 (50) 10 (71) 4 (33) .44
Comorbidity# 6 (4) 79 (59) 4 (44) 24 (60) 28 (58) 10 (59) 13 (68) .92
ICD shock 18 (13) 11 (9) 0 (0) 2 (5) 7 (16) 1 (7) 1 (7) .009
Smoking 0 (0) 21 (15) 0 (0) 5 (12) 7 (14) 6 (33) 3 (15) <.001
Medication use
Amiodarone 0 (0) 17 (12) 2 (22) 5 (12) 4 (8) 0 (0) 6 (30) <.001
ACE inhibitors 0 (0) 126 (91) 9 (100) 36 (86) 47 (94) 16 (89) 18 (90) .021
Beta-blockers 0 (0) 108 (78) 9 (100) 33 (79) 42 (84) 12 (67) 12 (60) <.001
Statins 0 (0) 84 (60) 6 (67) 24 (57) 32 (64) 10 (56) 12 (60) .97
Psychotropic medication 0 (0) 33 (24) 0 (0) 6 (14) 16 (32) 3 (17) 8 (40) <.001
Psychological functioning
Anxiety (STAI-S C 40) 2 (1) 59 (43) 1 (11) 10 (24) 22 (45) 12 (71) 14 (70) <.001
Depression (PHQ-
9 C 10)
1 (1) 32 (23) 0 (0) 0 (0 13 (26) 8 (44) 11 (55) <.001
Type D personality 1 (1) 32 (23) 0 (0) 6 (14) 10 (20) 7 (39) 9 (45) <.001
ACE angiotensin-converting enzyme; ESV end-systolic volume; ICD implantable cardioverter-defibrillator; LBBB left bundle branch block;
NYHA New York Heart Association; SD standard deviation; sec. secondary
* Results are presented as n (%), unless otherwise indicated. Significant results are printed in bold (Bonferroni’s corrected p value = 0.05/
72 = 6.9e-4)
 p values were obtained using adjusted Step-3-Dependent analysis procedures in Latent GOLD 5.0. All other values were observed values
obtained using SPSS
 Defined as primary education versus secondary education and higher
§ Upgrade from another implantable device, either (biventricular) pacemaker or ICD without cardiac resynchronization therapy
|| Echocardiographic response was defined as a decrease in left ventricular end-systolic volume of C15 % measured at 6-month follow-up
# Comorbidity = atrial fibrillation, chronic obstructive pulmonary disease, diabetes, or renal failure
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Furthermore, a trend was found for echocardiographic
response, with patients in the improving quality of life
trajectory more often showing echocardiographic response
after 6 months of CRT as compared with patients in the
deteriorating quality of life trajectory (71 vs. 33 %,
p = .052).
Trajectories of social limitation (KCCQ-SL)
Based on the BIC, a four-class model was preferred for
social limitation (Table 1). The class sizes of the social
limitation trajectories varied between 11 (8 %) and 66
(47 %), and the trajectories explained 66 % of the total
variance in KCCQ-SL scores. Trajectories differed from
each other with respect to intercept (Wald (=) 462.73,
p\ .001) and time slope (Wald (=) 34.90, p\ .001).
All KCCQ-SL trajectories showed an initial improve-
ment from baseline to 2-month follow-up, ranging from 7.6
to 27.3 points (Fig. 1c). After this initial improvement in
social limitation, all but one trajectory showed subsequent
stability between short- and long-term follow-up, whereas
patients in the ‘Very poor’ trajectory reported increased
social limitations during follow-up. The ‘Moderate-Ade-
quate’ trajectory comprised the largest group of patients
(47 %), with a mean score between 39.9 and 58.3 over
time.
Demographic, clinical, and psychological characteristics
at baseline stratified by KCCQ-SL status class are given in
Table 4. The KCCQ-SL classes showed different percent-
ages according to NYHA class III/IV, ICD shock, and
psychotropic medication. NYHA class III/IV and use of
psychotropic medication were associated with more social
limitation. The relationship between ICD shock and social
limitation was less clear. The highest percentages of ICD
shock were found in patients in the ‘Moderate-Adequate’
trajectory (17 %), whereas in all other trajectories none or
only 5 % of patients received a shock.
Discussion
This is the first study to examine the trajectories and
associates of disease-specific health status in HF patients
receiving a CRT-D device. Latent class analyses identified
five trajectories for physical health status and quality of
life, and four trajectories for social limitation. All health
status trajectories showed an initial improvement in the
first 2 months post-implantation, after which most trajec-
tories displayed a stable pattern between short- and long-
term follow-up. Low educational level, NYHA class III/IV,
smoking, no use of beta-blockers, use of psychotropic
medication, anxiety, depression, and Type D personality
were found to be associated with poorer health status in
univariate/unadjusted analyses. The relationship between
ICD shocks/use of amiodarone and health status was less
clear. Interestingly, subgroups of patients (12–20 %) who
reported poor health status at baseline improved to a good
health status level at 2-month follow-up, with these patients
being able to retain their improved health status up to
14 months post-implantation.
The results of the present study indicate that levels of
disease-specific health status vary considerably across
subgroups of CRT-D patients, which is not surprising given
the inherent heterogeneity of HF and differences in
patients’ response to CRT. However, these subgroups
would not have been identified if we had only calculated
changes in health status for the total sample.
The finding of early improvement in disease-specific
health status after CRT-D implantation followed by stabi-
lization between short- and long-term follow-up is in line
with a recent study examining mean and individual health
status scores of HF patients receiving a left ventricular
assist device [17]. The early health status improvement
could be the result of incipient reverse remodeling and
enhanced exercise capacity induced by the implanted
device. However, it could also represent a study bias, as
patients participating in research might exhibit better
compliance with respect to intake of medication, recom-
mended health behaviors, etc. Finally, a placebo effect
could contribute to the early health status improvement
observed after device implantation. Irrespective of the
cause(s) of this early improvement, our results indicate that
levels of disease-specific health status at short-term follow-
up are a good indicator of experienced health status at long-
term follow-up. However, this needs to be confirmed in
future studies, before any implications for clinical practice
can be drawn with respect to advocating a one-time
assessment of patient-reported health status rather than
multiple assessments.
With respect to demographic characteristics, a lower
educational level was found to be a significant associate of
poorer health status trajectories. This result is in agreement
with the finding of an earlier HF study, suggesting that
poorly educated patients [18] may require different or
additional interventions to improve their health status. In
addition, female gender was identified as a variable dis-
tinguishing between patients improving versus not
improving from impaired to good health status between
baseline and short-term follow-up. Female patients might
be more prone to experience placebo effects and therefore
have a greater chance of being in the improved health
status trajectory compared with men. Moreover, women
have shown greater echocardiographic evidence of reverse
cardiac remodeling after CRT than men [19].
With respect to clinical characteristics, only NYHA III/
IV classification was found to be clearly related with
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classification into poorer health status trajectories, which is
in line with the findings of previous HF studies in which a
higher NYHA classification independently predicted
impaired HF-specific health status [20, 21]. Furthermore,
results from the HF-ACTION trial found that NYHA class
III was associated with a 12.73-point lower KCCQ score
than NYHA II [22]. However, NYHA classification has
been criticized for its interrater reliability and validity
problems, and most of the variation in health status cannot
be explained by NYHA class alone [23]. Hence, assess-
ment of HF-specific health status might have additional
value in clinical practice to assess patients’ functional
status. Although we found a significant association
between ICD shocks and classification into health status
Table 4 Baseline characteristics stratified by social limitation trajectories after CRT-D implantation*
Baseline variable Missing Total Very good–Excellent Adequate–Very good Moderate–Adequate Very poor p value
(n, %) (n = 139) (n = 21) (n = 41) (n = 66) (n = 11)
Demographics
Mean age (SD) 0 (0) 65.7 (10.1) 64.1 (10.7) 66.9 (8.8) 65.3 (10.8) 66.4 (10.5) .89
Male gender 0 (0) 97 (70) 15 (71) 26 (63) 48 (73) 8 (73) .64
Having a partner 0 (0) 113 (81) 19 (91) 34 (83) 53 (80) 7 (64) .46
Low education 1 (1) 18 (13) 2 (10) 2 (5) 12 (19) 2 (18) .30
Being employed 1 (1) 30 (22) 6 (29) 9 (23) 13 (20) 2 (18) .74
Clinical variables
Upgrade§ 0 (0) 36 (26) 4 (19) 13 (32) 16 (24) 3 (27) .79
ICD as sec. prevention 0 (0) 26 (19) 7 (33) 6 (15) 9 (14) 4 (36) .05
Ischemic etiology 0 (0) 68 (49) 13 (62) 14 (34) 36 (55) 5 (46) .15
NYHA class III/IV 0 (0) 110 (79) 8 (38) 32 (78) 61 (92) 9 (82) <.001
Mean LVEF (SD) 6 (4) 24.9 (8.6) 28.3 (9.7) 23.9 (7.9) 24.5 (8.6) 24.8 (8.7) .38
Mean QRS (SD) 11 (8) 162 (25) 162 (27) 168 (26) 160 (23) 158 (27) .82
LBBB 28 (20) 60 (54) 12 (63) 21 (58) 24 (49) 3 (43) .53
ESV responder|| 25 (18) 61 (54) 12 (63) 21 (57) 27 (53) 1 (14) .40
Comorbidity# 6 (4) 79 (59) 8 (38) 23 (59) 43 (69) 5 (46) .08
ICD shock 18 (13) 11 (9) 0 (0) 2 (5) 9 (17) 0 (0) <.001
Smoking 0 (0) 21 (15) 1 (5) 6 (15) 12 (18) 2 (18) .50
Medication use
Amiodarone 0 (0) 17 (12) 3 (14) 3 (7) 6 (9) 5 (46) .032
ACE inhibitors 0 (0) 126 (91) 17 (81) 38 (93) 60 (91) 11 (100) .40
Beta-blockers 0 (0) 108 (78) 18 (86) 32 (78) 53 (80) 5 (46) .046
Statins 0 (0) 84 (60) 14 (67) 24 (59) 39 (59) 7 (64) .94
Psychotropic medication 0 (0) 33 (24) 0 (0) 5 (12) 24 (36) 4 (36) <.001
Psychological functioning
Anxiety (STAI-S C 40) 2 (1) 59 (43) 4 (19) 16 (36) 31 (48) 8 (73) .031
Depression
(PHQ-9 C 10)
1 (1) 32 (23) 1 (5) 3 (7) 22 (33) 6 (55) .002
Type D personality 1 (1) 32 (23) 2 (10) 7 (17) 19 (29) 4 (36) .12
ACE angiotensin-converting enzyme; ESV end-systolic volume; ICD implantable cardioverter-defibrillator; LBBB left bundle branch block;
NYHA New York Heart Association; SD standard deviation; sec. secondary
* Results are presented as n (%), unless otherwise indicated. Significant results are printed in bold (Bonferroni’s corrected p value = 0.05/
72 = 6.9e-4)
 p values were obtained using adjusted Step-3-Dependent analysis procedures in Latent GOLD 5.0. All other values were observed values
obtained using SPSS
 Defined as primary education versus secondary education and higher
§ Upgrade from another implantable device, either (biventricular) pacemaker or ICD without cardiac resynchronization therapy
|| Echocardiographic response was defined as a decrease in left ventricular end-systolic volume of C15 % measured at 6-month follow-up
# Comorbidity = atrial fibrillation, chronic obstructive pulmonary disease, diabetes, or renal failure
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trajectories, we could not identify a clear direction of the
relationship with the highest percentage of shocks found in
patients reporting adequate to good health status. This
corroborates earlier findings on the influence of ICD shocks
on patient-reported outcomes, which are mixed [24].
Finally, with respect to echocardiographic CRT response,
our research group has demonstrated a large discrepancy
between echocardiographic response and health status
improvement after CRT [25]. However, although
echocardiographic response was not identified as an asso-
ciate of poorer health status in the current study, patients
reporting the lowest health status levels over time also
showed the lowest percentage of response. Furthermore,
echocardiographic response was identified as a variable
distinguishing between patients improving versus those not
improving from poor to good health status between base-
line and short-term follow-up. So, patients reporting per-
sistently poor health status after implantation might
constitute end-stage HF patients, with enlarged hearts that
are ‘beyond repair.’
Classification into poorer disease-specific health status
trajectories was found to be particularly associated with
patients’ psychological profile (i.e., use of psychotropic
medication, anxiety, depression, and Type D personality)
and less with their clinical status (except for NYHA clas-
sification), which seems to be consistent with earlier
research [17, 20, 26, 27]. Identification of patients with a
vulnerable psychological profile would provide the
opportunity to offer them appropriate treatment. It seems
feasible to simultaneously screen for patients’ health status
and their personality. For patients reporting poor health
status without experiencing anxiety/depression or having a
Type D personality, cardiac rehabilitation may suffice.
While for patients reporting poor health status and having a
distressed personality profile, additional psychological and
behavioral intervention may be desirable. Anxiety and
depression may be improved by cognitive behavioral
therapy, mindfulness, relaxation therapy, and supplemen-
tary pharmacotherapy depending on patients’ preferences
and needs, while intervention strategies for Type D could
focus on improvement in mood, health status, health-re-
lated behaviors, and interpersonal functioning [28].
This study is limited by the relatively small patient
sample, making it underpowered to perform multivariable
analyses to examine which demographic, clinical, and
psychological characteristics independently predict health
status class membership. However, the present study also
has several strengths, including the repeated assessment of
disease-specific health status at four time points and the use
of a novel and innovative latent class regression technique,
which permits the identification of patients reporting per-
sistently low health status, who may need additional care
above and beyond standard HF management.
Conclusion
The results of the present study indicate that levels of
disease-specific health status vary considerably across
subgroups of CRT-D patients. Classification into poorer
disease-specific health status trajectories seems to be par-
ticularly associated with patients’ psychological profile and
NYHA classification, although this conclusion should be
interpreted with caution as no multivariate analyses could
be performed. Our results do suggest that individual dif-
ferences in patients’ profile should be considered in the
timely identification of patients who are at increased risk of
poor health status. This is of utmost importance, since poor
patient-reported health status has been shown to predict
mortality and rehospitalization in HF patients independent
of traditional risk factors. The timely identification and
monitoring of CRT-D patients with poor disease-specific
health status (a KCCQ score\ 50) and/or a distressed
psychological profile (anxiety, depression and/or Type D
personality) is paramount, as they may benefit from cardiac
rehabilitation in combination with psychological
intervention.
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